Vanguard Group Inc Agios Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 5,631,321 shares of AGIO stock, worth $169 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,631,321

Previous 5,545,982 1.54%

Holding current value

$169 Million

Previous $246 Million 24.9%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$32.86 - $61.64 $2.8 Million - $5.26 Million	85,339 Added 1.54%	5,631,321 $185 Million
Q3 2024 Nov 13, 2024	BUY	$41.19 - $49.72 $2.03 Million - $2.45 Million	49,245 Added 0.9%	5,545,982 $246 Million
Q2 2024 Aug 13, 2024	SELL	$27.55 - $48.83 $2.07 Million - $3.68 Million	-75,284 Reduced 1.35%	5,496,737 $237 Million
Q1 2024 May 10, 2024	BUY	$21.32 - $34.81 $950,509 - $1.55 Million	44,583 Added 0.81%	5,572,021 $163 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $1.2 Million - $1.47 Million	59,851 Added 1.09%	5,527,438 $123 Million
Q3 2023 Nov 14, 2023	SELL	$24.36 - $28.18 $1.27 Million - $1.47 Million	-52,000 Reduced 0.94%	5,467,587 $135 Million
Q2 2023 Aug 14, 2023	BUY	$21.38 - $29.19 $2.05 Million - $2.79 Million	95,660 Added 1.76%	5,519,587 $156 Million
Q1 2023 May 15, 2023	BUY	$21.74 - $30.93 $1.93 Million - $2.75 Million	88,851 Added 1.67%	5,423,927 $125 Million
Q4 2022 Feb 10, 2023	BUY	$24.81 - $31.52 $2.73 Million - $3.47 Million	109,979 Added 2.1%	5,335,076 $150 Million
Q3 2022 Nov 14, 2022	BUY	$19.51 - $34.14 $417,435 - $730,459	21,396 Added 0.41%	5,225,097 $148 Million
Q2 2022 Aug 12, 2022	BUY	$17.06 - $31.42 $2.01 Million - $3.7 Million	117,887 Added 2.32%	5,203,701 $115 Million
Q1 2022 May 13, 2022	BUY	$26.68 - $34.81 $459,536 - $599,567	17,224 Added 0.34%	5,085,814 $148 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $11.2 Million - $18.8 Million	-377,231 Reduced 6.93%	5,068,590 $167 Million
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $6.06 Million - $8.41 Million	-144,585 Reduced 2.59%	5,445,821 $251 Million
Q2 2021 Aug 13, 2021	BUY	$52.06 - $61.27 $291 Million - $343 Million	5,590,406 New	5,590,406 $308 Million

Others Institutions Holding AGIO

# of Institutions

239

Shares Held

60M

Call Options Held

270K

Put Options Held

332K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.64B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Agios Pharmaceuticals, Inc. Transaction History